If a patient rings a drug company asking for information about one of the company’s drugs that he or she is taking, the company cannot answer. Companies are forbidden to “come between” patients and their doctors. Is that right? This question was discussed last week at a conference in Monte Carlo of some 3000 regulators, […]
Richard Smith: Should drug companies be free to give information to patients?
